Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2025 Mar 13

PMID 40075754

Authors

Nawar Maher

Samir Mouhssine

Bassam Francis Matti

Alaa Fadhil Alwan

Gianluca Gaidano

Affiliations

Soon will be listed here.

Abstract

Histological transformation (HT) into aggressive lymphoma is a turning point in a significant fraction of patients affected by indolent lymphoproliferative neoplasms, namely, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), marginal zone lymphomas (MZLs), and lymphoplasmacytic lymphoma (LPL) [...].

References

Casulo C, Friedberg J . Transformation of marginal zone lymphoma (and association with other lymphomas). Best Pract Res Clin Haematol. 2017; 30(1-2):131-138. DOI: 10.1016/j.beha.2016.08.029. View

Conconi A, Franceschetti S, Aprile von Hohenstaufen K, Margiotta-Casaluci G, Stathis A, Moccia A . Histologic transformation in marginal zone lymphomas†. Ann Oncol. 2015; 26(11):2329-35. DOI: 10.1093/annonc/mdv368. View

Hannier S, Triebel F . The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes. Int Immunol. 1999; 11(11):1745-52. DOI: 10.1093/intimm/11.11.1745. View

Sherr C . Ink4-Arf locus in cancer and aging. Wiley Interdiscip Rev Dev Biol. 2012; 1(5):731-41. PMC: 3434949. DOI: 10.1002/wdev.40. View

Mouhssine S, Maher N, Matti B, Alwan A, Gaidano G . Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms. Int J Mol Sci. 2024; 25(6). PMC: 10970225. DOI: 10.3390/ijms25063234. View

Salido M, Baro C, Oscier D, Stamatopoulos K, Dierlamm J, Matutes E . Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group. Blood. 2010; 116(9):1479-88. DOI: 10.1182/blood-2010-02-267476. View

Minden M, Ubelhart R, Schneider D, Wossning T, Bach M, Buchner M . Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012; 489(7415):309-12. DOI: 10.1038/nature11309. View

Dhanasekaran R, Deutzmann A, Mahauad-Fernandez W, Hansen A, Gouw A, Felsher D . The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2021; 19(1):23-36. PMC: 9083341. DOI: 10.1038/s41571-021-00549-2. View

Hernandez Borrero L, El-Deiry W . Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer. 2021; 1876(1):188556. PMC: 8730328. DOI: 10.1016/j.bbcan.2021.188556. View

10.

Alaggio R, Amador C, Anagnostopoulos I, Attygalle A, de Oliveira Araujo I, Berti E . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748. PMC: 9214472. DOI: 10.1038/s41375-022-01620-2. View

11.

Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer J . MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 1998; 273(20):12203-9. DOI: 10.1074/jbc.273.20.12203. View

12.

Triebel F, JITSUKAWA S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequignot E . LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med. 1990; 171(5):1393-405. PMC: 2187904. DOI: 10.1084/jem.171.5.1393. View

13.

Hunter Z, Xu L, Yang G, Zhou Y, Liu X, Cao Y . The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood. 2013; 123(11):1637-46. DOI: 10.1182/blood-2013-09-525808. View

14.

Engeland K . Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022; 29(5):946-960. PMC: 9090780. DOI: 10.1038/s41418-022-00988-z. View

15.

Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M . Detection of early seeding of Richter transformation in chronic lymphocytic leukemia. Nat Med. 2022; 28(8):1662-1671. PMC: 9388377. DOI: 10.1038/s41591-022-01927-8. View

16.

Parry E, Leshchiner I, Guieze R, Johnson C, Tausch E, Parikh S . Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nat Med. 2023; 29(1):158-169. PMC: 10155825. DOI: 10.1038/s41591-022-02113-6. View

17.

Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B . The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2010; 117(2):563-74. PMC: 3031480. DOI: 10.1182/blood-2010-05-284984. View

18.

Sagaert X, De Paepe P, Libbrecht L, Vanhentenrijk V, Verhoef G, Thomas J . Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol. 2006; 24(16):2490-7. DOI: 10.1200/JCO.2006.05.6150. View

19.

Cerhan J, Habermann T . Epidemiology of Marginal Zone Lymphoma. Ann Lymphoma. 2021; 5. PMC: 8020862. DOI: 10.21037/aol-20-28. View

20.

Martines C, Chakraborty S, Vujovikj M, Gobessi S, Vaisitti T, Deaglio S . Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo. Blood. 2022; 140(22):2335-2347. DOI: 10.1182/blood.2022016272. View